(Q48837496)

16 February 2018

title

Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix (English)

1 reference

16 February 2018

0 references

Byron Asimakopoulos

1

1 reference

16 February 2018

Nikos Nikolettos

series ordinal

2

1 reference

16 February 2018

Safaa Al-Hasani

series ordinal

3

1 reference

16 February 2018

publication date

1 January 2002

1 reference

16 February 2018

Reproductive BioMedicine Online

published in

1 reference

16 February 2018

volume

5 Suppl 1

1 reference

16 February 2018

page(s)

52-56

1 reference

16 February 2018

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Comparison of cryopreservation of supernumerary pronuclear human oocytes obtained after intracytoplasmic sperm injection (ICSI) and after conventional in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Pregnancies achieved after frozen-thawed pronuclear oocytes obtained by intracytoplasmic sperm injection with spermatozoa extracted from frozen-thawed testicular tissues from non-obstructive azoospermic men.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

New approaches to ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Hormonal responses to the new potent GnRH antagonist Cetrorelix

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2811%2960217-4

7 January 2021

10.1016/S1472-6483(11)60217-4

Identifiers

DOI

0 references

1 reference

16 February 2018